Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355

1.

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ.

Circulation. 2004 May 4;109(17):2058-67. Epub 2004 Apr 12.

2.

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.

Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ.

Circulation. 2002 Aug 20;106(8):913-9.

3.

C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells.

Suh W, Kim KL, Choi JH, Lee YS, Lee JY, Kim JM, Jang HS, Shin IS, Lee JS, Byun J, Jeon ES, Kim DK.

Biochem Biophys Res Commun. 2004 Aug 13;321(1):65-71.

PMID:
15358216
4.

C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells.

Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2476-82. Epub 2006 Aug 24.

5.

Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.

Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S.

Circulation. 2004 Mar 23;109(11):1392-400. Epub 2004 Mar 1.

6.

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.

Goya K, Sumitani S, Xu X, Kitamura T, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S, Kawase I.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):658-63. Epub 2004 Jan 29.

7.

Cyclosporin A suppresses proliferation of endothelial progenitor cells: involvement of nitric oxide synthase inhibition.

Yang L, Yang XC, Yang JK, Guo YH, Yi FF, Fan Q, Liu XL.

Intern Med. 2008;47(16):1457-64. Epub 2008 Aug 15.

8.

C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.

Chen J, Huang L, Song M, Yu S, Gao P, Jing J.

J Cardiovasc Pharmacol. 2009 May;53(5):359-67. doi: 10.1097/FJC.0b013e31819b5438.

PMID:
19276989
9.

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.

Laufs U, Werner N, Link A, Endres M, Wassmann S, Jürgens K, Miche E, Böhm M, Nickenig G.

Circulation. 2004 Jan 20;109(2):220-6. Epub 2003 Dec 22.

10.

C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products.

Chen J, Jin J, Song M, Dong H, Zhao G, Huang L.

Gene. 2012 Apr 1;496(2):128-35. doi: 10.1016/j.gene.2011.12.039. Epub 2012 Jan 18.

PMID:
22301267
11.

[Inhibitory effect of siRNA targeting HIF-1alpha on differentiation of peripheral blood endothelial progenitor cells].

Jiang M, Wang CQ, Wang BY, Huang DJ.

Ai Zheng. 2005 Nov;24(11):1293-300. Chinese.

PMID:
16552951
12.

Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.

Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, Bauersachs J.

Diabetes. 2007 Mar;56(3):666-74.

13.

Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase.

Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, Han ZC.

J Lipid Res. 2006 Jun;47(6):1227-37. Epub 2006 Mar 7.

14.
15.

Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.

Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.

Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9. doi: 10.1152/ajpendo.90780.2008. Epub 2009 Apr 7.

16.

Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.

Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O.

Circ Res. 2004 Jul 23;95(2):154-61. Epub 2004 Jun 17.

17.

Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival.

DiFabio JM, Thomas GR, Zucco L, Kuliszewski MA, Bennett BM, Kutryk MJ, Parker JD.

J Pharmacol Exp Ther. 2006 Jul;318(1):117-23. Epub 2006 Apr 18.

19.

Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.

Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J.

Circ Res. 2007 Feb 16;100(3):434-43. Epub 2007 Jan 18.

20.

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.

Kang DH, Park SK, Lee IK, Johnson RJ.

J Am Soc Nephrol. 2005 Dec;16(12):3553-62. Epub 2005 Oct 26.

Supplemental Content

Support Center